Revista Medico-Chirurgicala 2009-01-01

[The withdrawal syndrome in benzodiazepine dependence and its management].

A O Străulea, V Chiriţă

Index: Rev. Med. Chir. Soc. Med. Nat. Iasi. 113(3) , 879-84, (2009)

Full Text: HTML

Abstract

The authors present the result of an observational study about the withdrawal syndrome in benzodiazepine dependence, and the aspect of identifying withdrawal symptoms, effective communication with the patient and the structure of withdrawal programmes.The study included a number of 22 pacients hospitalised in the Drug-Dependence Clinic of Iaşi between January 2006 - December 2008.The present article consists of data covering current issues in the area of withdrawal syndrome in benzodiazepine dependence. The most prescribed benzodiazepines were diazepam (10 cases), followed by alprazolam (5 cases) and nitrazepam (4 cases). The clinical manifestations such as anxiety, insomnia, concentration problems, fatigability were present at all patients.

Related Compounds

  • Nitrazepam

Related Articles:

Sedative-hypnotics are widely abused by drivers apprehended for driving under the influence of drugs.

2015-06-01

[Ther. Drug Monit. 37 , 339-46, (2015)]

Determination of low levels of benzodiazepines and their metabolites in urine by hollow-fiber liquid-phase microextraction (LPME) and gas chromatography-mass spectrometry (GC-MS).

2015-01-15

[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 975 , 24-33, (2014)]

Cleaning up blood samples using a modified "QuEChERS" procedure for the determination of drugs of abuse and benzodiazepines by UPLC-MSMS(☆).

2014-10-01

[Forensic Sci. Int. 243 , 99-106, (2014)]

Simple and sensitive screening and quantitative determination of 88 psychoactive drugs and their metabolites in blood through LC–MS/MS: Application on postmortem samples

2014-11-01

[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 970 , 1-7, (2014)]

Urine Mescaline Screening With a Biochip Array Immunoassay and Quantification by Gas Chromatography-Mass Spectrometry.

2015-12-01

[Ther. Drug Monit. 37 , 805-11, (2015)]

More Articles...